Please note…

You are now on the ey.com Global site. To return to the ey.com United States site or other country site, click on the Global (English) link on the upper right of this page, and select your preferred country site.

x
Skip to main navigation

Ernst & Young Global Biotechnology Center - Ernst & Young - Global

  • Share

Commitment and experience for changing times

More than any other technology, biotechnology has the potential to alter our lives in a positive way. And by achieving this potential, today’s biotech companies are delivering new levels of health, prosperity and sustainability — across the world. But with uncertain capital markets, increasing regulation, growing pricing pressures, competition for acquisitions and an evolving health care environment around the world, this sector faces unprecedented challenges. Ernst & Young has been a pioneering presence in the biotechnology industry. We were the first professional services firm to build a practice dedicated to serving your industry. We’ve stayed committed to your business with our leading reports and our network of knowledgeable professionals. So it’s not surprising that we serve more biotech companies than any other professional services firm.

Through the Ernst & Young’s Global Life Science Center, we bring together a worldwide team of industry professionals to help you achieve your potential — a team with deep experience in providing assurance, tax, transaction and advisory services specific to biotechnology companies around the globe. It’s a team that works to anticipate market trends and their implications, so you get practical advice on the right way forward for your organization. We also publish a series of reports to bring you clear insights on accounting, tax, transaction, compliance and business process issues specific and often unique to the biotech sector.

Whether it’s raising capital, forming the right alliances, improving operations, expanding globally or gaining insights into the market, we can give you a clear perspective on how to drive value in today’s complex, competitive and risk-driven environment.

German biotechnology report 2011

Can the German biotech industry continue to grow at a pace that will help it maintain a sustainable future? Learn more about the defining events.

Beyond borders: global biotechnology report 2011

How sustainable is today’s biotechnology industry? After slowly recovering from the recession, bigger companies are proving more successful than smaller ones. Will this trend continue and what changes are ahead for biotech. Learn more in our 25th anniversary edition of Beyond Borders.

Progressions 2011: Building Pharma 3.0

A transformation of the pharmaceutical industry is underway as companies begin shifting from producing new medicines to demonstrating improved health outcomes. No longer the dominant health care player, pharma has a new focus. We report on pharma’s progress in creating new business models and partnerships focused on technology and sustainability.

2011 Italian Biotechnology Report

How is the Italian biotechnology field balancing its growth in human health, agro-food, and industry work? Learn more about this growing market.

What Europe has to offer biotechnology companies

Europe has the potential to be a world leader in biotechnology, but more needs to be done by industry and regulatory authorities to get there.

Woman looking through window in office
Back to top